Breast Biopsy Devices Market, 2012 to 2023
Global Breast Biopsy Devices Market
Breast cancer is the disease characterized by abnormal growth of cells in the breast tissue. Breast biopsy devices are used to diagnose breast cancer by removal of the sample from the breast tissue for the laboratory testing. The breast biopsy is preferred when the formation of lumps in the breast or abnormal change in nipples such as congealing, scaling, cellulite, or crusting of the skin. Various types of breast biopsy devices are preferred for the breast cancer diagnosis such as vacuum-powered biopsy, fine-needle aspiration, and core needle biopsy among others.
Increase in the global breast cancer prevalence rate, changes in lifestyle such as consumption of tobacco, alcohol and food habits, growing in the female population with hormonal imbalance, an increase in the breast cancer screening programs around the globe are anticipated to fuel the breast biopsy devices market over the forecast period. In addition, technological advancements with minimally invasive or non-invasive diagnostic procedure, favourable reimbursement policies, and rising investment by the companies for R&D activities are expected to boost the breast biopsy devices market. However, stringent regulatory guidelines, infections associated with the breast biopsy devices, and the high cost of the procedures are dampening the growth of Breast Biopsy Devices Market.
Breast biopsy devices market segmented based on device type, procedure type, guidance type, and end user
Based on the device type, breast biopsy devices market is segmented into the following:
Needles
Forceps
Guns
Others
Based on the procedure type, breast biopsy devices market is segmented into the following:
Core needle biopsy
Vacuum-assisted core biopsy
Fine needle aspiration biopsy
Stereotactic core needle biopsy
Surgical biopsy
Others
Based on guidance type, breast biopsy devices market is segmented into the following:
Ultrasound-guided biopsy
Magnetic resonance imaging (MRI) guided biopsy
Mammography guided stereotactic guided biopsy
Others
Based on the end user, breast biopsy devices market is segmented into the following:
Hospitals
Clinics
Ambulatory surgical centres
Laboratories
Breast biopsy devices market is growing at a significant CAGR over the forecast period. The breast biopsy is mandatory for the diagnosis of breast cancer which cannot be confirmed by breast mammograms. Increase in the global breast cancer incidences (according to World Cancer Research Fund International, about 1.7 Mn new cases were observed in 2012) propels the breast cancer devices market over the forecast period. Acquisitions and mergers, collaborations, patent approvals, and technological advancements are the key strategies followed by the companies for increasing their revenue in the breast biopsy devices market. For instance, in 2014, Leica Biosystems (Danaher Corporation) acquired Devicor Medical Products for strengthening its breast biopsy devices portfolio. Moreover, In January 2015, Intact Medical Corporation received FDA approval for the minimally-invasive breast biopsy device. In addition, fundraising by the start-up companies for the innovation of novel devices also propels the breast biopsy devices market over the forecast period.
Geographically, breast biopsy devices market is segmented into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific. North America has a lucrative growth in breast biopsy devices market owing to increase in the prevalence of breast cancer (according to Centre for Disease Control and Prevention 2014, about 236,968 women and 2,141 men were diagnosed with breast cancer in U.S.), technological advancements, and increase in healthcare expenditure in the region. Europe has a significant share owing to rise in prevalence of breast cancer majorly in Italy, Greece, Finland, Germany, and Netherlands where the prevalence rate is approximately more than 400 per 100,000 population. In addition, high adoption of novel technologies, development in healthcare infrastructure, changes in lifestyle, and government initiations to create awareness about breast cancer diagnosis programs are anticipated to fuel the breast biopsy devices market. Asia Pacific is an emerging region for the breast biopsy devices market due to rise in female geriatric population majorly in Japan, China, and India. Moreover, increase in per capita income, rise in awareness about the breast cancer diagnosis, and rise in R&D for developing the minimally invasive procedures are driving the breast biopsy devices market.
Some of the players in breast biopsy devices market are Medtronic, Inc. (Ireland), Becton, Dickinson and Company (U.S.), Hologic Inc. (U.S.), C.R. Bard, Inc. (U.S.), Planmed Oy (Finland), Scion Medical Technologies, LLC (U.S.), and Leica Biosystems (Danaher Corporation) to name a few.
In August 2017, Hologic has launched Brevera breast biopsy system for the real-time breast biopsy and verification
Report Outline:
The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments, and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Breast cancer is the disease characterized by abnormal growth of cells in the breast tissue. Breast biopsy devices are used to diagnose breast cancer by removal of the sample from the breast tissue for the laboratory testing. The breast biopsy is preferred when the formation of lumps in the breast or abnormal change in nipples such as congealing, scaling, cellulite, or crusting of the skin. Various types of breast biopsy devices are preferred for the breast cancer diagnosis such as vacuum-powered biopsy, fine-needle aspiration, and core needle biopsy among others.
Increase in the global breast cancer prevalence rate, changes in lifestyle such as consumption of tobacco, alcohol and food habits, growing in the female population with hormonal imbalance, an increase in the breast cancer screening programs around the globe are anticipated to fuel the breast biopsy devices market over the forecast period. In addition, technological advancements with minimally invasive or non-invasive diagnostic procedure, favourable reimbursement policies, and rising investment by the companies for R&D activities are expected to boost the breast biopsy devices market. However, stringent regulatory guidelines, infections associated with the breast biopsy devices, and the high cost of the procedures are dampening the growth of Breast Biopsy Devices Market.
Breast biopsy devices market segmented based on device type, procedure type, guidance type, and end user
Based on the device type, breast biopsy devices market is segmented into the following:
Needles
Forceps
Guns
Others
Based on the procedure type, breast biopsy devices market is segmented into the following:
Core needle biopsy
Vacuum-assisted core biopsy
Fine needle aspiration biopsy
Stereotactic core needle biopsy
Surgical biopsy
Others
Based on guidance type, breast biopsy devices market is segmented into the following:
Ultrasound-guided biopsy
Magnetic resonance imaging (MRI) guided biopsy
Mammography guided stereotactic guided biopsy
Others
Based on the end user, breast biopsy devices market is segmented into the following:
Hospitals
Clinics
Ambulatory surgical centres
Laboratories
Breast biopsy devices market is growing at a significant CAGR over the forecast period. The breast biopsy is mandatory for the diagnosis of breast cancer which cannot be confirmed by breast mammograms. Increase in the global breast cancer incidences (according to World Cancer Research Fund International, about 1.7 Mn new cases were observed in 2012) propels the breast cancer devices market over the forecast period. Acquisitions and mergers, collaborations, patent approvals, and technological advancements are the key strategies followed by the companies for increasing their revenue in the breast biopsy devices market. For instance, in 2014, Leica Biosystems (Danaher Corporation) acquired Devicor Medical Products for strengthening its breast biopsy devices portfolio. Moreover, In January 2015, Intact Medical Corporation received FDA approval for the minimally-invasive breast biopsy device. In addition, fundraising by the start-up companies for the innovation of novel devices also propels the breast biopsy devices market over the forecast period.
Geographically, breast biopsy devices market is segmented into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific. North America has a lucrative growth in breast biopsy devices market owing to increase in the prevalence of breast cancer (according to Centre for Disease Control and Prevention 2014, about 236,968 women and 2,141 men were diagnosed with breast cancer in U.S.), technological advancements, and increase in healthcare expenditure in the region. Europe has a significant share owing to rise in prevalence of breast cancer majorly in Italy, Greece, Finland, Germany, and Netherlands where the prevalence rate is approximately more than 400 per 100,000 population. In addition, high adoption of novel technologies, development in healthcare infrastructure, changes in lifestyle, and government initiations to create awareness about breast cancer diagnosis programs are anticipated to fuel the breast biopsy devices market. Asia Pacific is an emerging region for the breast biopsy devices market due to rise in female geriatric population majorly in Japan, China, and India. Moreover, increase in per capita income, rise in awareness about the breast cancer diagnosis, and rise in R&D for developing the minimally invasive procedures are driving the breast biopsy devices market.
Some of the players in breast biopsy devices market are Medtronic, Inc. (Ireland), Becton, Dickinson and Company (U.S.), Hologic Inc. (U.S.), C.R. Bard, Inc. (U.S.), Planmed Oy (Finland), Scion Medical Technologies, LLC (U.S.), and Leica Biosystems (Danaher Corporation) to name a few.
In August 2017, Hologic has launched Brevera breast biopsy system for the real-time breast biopsy and verification
Report Outline:
The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments, and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL BREAST BIOPSY DEVICES MARKET INTRODUCTION
2.1. Global Breast Biopsy Devices Market – Taxonomy
2.2. Global Breast Biopsy Devices Market–Definitions
2.2.1. Device Type
2.2.2. Procedure Type
2.2.3. Guidance Type
2.2.4. End User
2.2.5. Region
3. GLOBAL BREAST BIOPSY DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Breast Biopsy Devices Market Dynamics – Factors Impact Analysis
3.6. Global Breast Biopsy Devices Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Breast Biopsy Devices Market– Product Innovations
3.8. Competitor Landscape
4. GLOBAL BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 – 2023
4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL BREAST BIOPSY DEVICES MARKET, BY DEVICE TYPE, 2012 - 2023
5.1. Core needle biopsy
5.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Vacuum-assisted core biopsy
5.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Fine needle aspiration biopsy
5.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Stereotactic core needle biopsy
5.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Surgical biopsy
5.5.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
6. GLOBAL BREAST BIOPSY DEVICES MARKET , BY PROCEDURE TYPE, 2016-2016 AND FORECAST 2017 - 2023
6.1. Needles
6.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.2. Forceps
6.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Guns
6.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
7. GLOBAL BREAST BIOPSY DEVICES MARKET FORECAST, BY GUIDANCE TYPE, 2012-2016 AND FORECAST 2017 - 2023
7.1. Ultrasound-guided biopsy
7.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Magnetic resonance imaging (MRI) guided biopsy
7.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Mammography guided stereotactic guided biopsy
7.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.4.3. Market Opportunity Analysis
8. GLOBAL BREAST BIOPSY DEVICES MARKET FORECAST, BY END USER, 2012-2016 AND FORECAST 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Clinics
8.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Ambulatory surgical centres
8.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
8.4. Laboratories
8.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.4.3. Market Opportunity Analysis
8.5. Laboratories
8.5.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.5.3. Market Opportunity Analysis
9. GLOBAL BREAST BIOPSY DEVICES MARKET FORECAST, BY REGION, 2012-2016 AND FORECAST 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East & Africa
9.5.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User and Region, 2012-2016 and Forecast 2017 – 2023
10. NORTH AMERICA BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 - 2023
10.1.1.Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Core needle biopsy
10.1.1.2. Vacuum-assisted core biopsy
10.1.1.3. Fine needle aspiration biopsy
10.1.1.4. Stereotactic core needle biopsy
10.1.1.5. Surgical biopsy
10.1.1.6. Others
10.1.2.Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.2.1. Needles
10.1.2.2. Forceps
10.1.2.3. Guns
10.1.2.4. Others
10.1.3.Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.3.1. Ultrasound-guided biopsy
10.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
10.1.3.3. Mammography guided stereotactic guided biopsy
10.1.3.4. Others
10.1.4.End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Clinics
10.1.4.3. Ambulatory surgical centres
10.1.4.4. Laboratories
10.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.5.1. U.S
10.1.5.2. Canada
10.1.6. North America Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
10.1.7. North America Breast Biopsy Devices Market Dynamics - Trends
11. EUROPE BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 - 2023
11.1.1. Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Core needle biopsy
11.1.1.2. Vacuum-assisted core biopsy
11.1.1.3. Fine needle aspiration biopsy
11.1.1.4. Stereotactic core needle biopsy
11.1.1.5. Surgical biopsy
11.1.1.6. Others
11.1.2. Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.2 Needles
11.1.2.1. Forceps
11.1.2.2. Guns
11.1.2.3. Others
11.1.3. Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.3.1. Ultrasound-guided biopsy
11.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
11.1.3.3. Mammography guided stereotactic guided biopsy
11.1.3.4. Others
11.1.4. End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Clinics
11.1.4.3. Ambulatory surgical centres
11.1.4.4. Laboratories
11.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Italy
11.1.5.5. Spain
11.1.5.6. Poland
11.1.5.7. Russia
11.1.5.8. Rest of Europe
11.1.6. Europe Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
11.1.7. Europe Breast Biopsy Devices Market Dynamics - Trends
12. ASIA-PACIFIC BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 - 2023
12.1.1. Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Core needle biopsy
12.1.1.2. Vacuum-assisted core biopsy
12.1.1.3. Fine needle aspiration biopsy
12.1.1.4. Stereotactic core needle biopsy
12.1.1.5. Surgical biopsy
12.1.1.6. Others
12.1.2. Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.2.1. Needles
12.1.2.2. Forceps
12.1.2.3. Guns
12.1.2.4. Others
12.1.3. Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.3.1. Ultrasound-guided biopsy
12.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
12.1.3.3. Mammography guided stereotactic guided biopsy
12.1.3.4. Others
12.1.4. End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Clinics
12.1.4.3. Ambulatory surgical centres
12.1.4.4. Laboratories
12.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of APAC
12.1.6. Asia-Pacific Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
12.1.7. Asia-Pacific Breast Biopsy Devices Market Dynamics - Trends
13. LATIN AMERICA BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 - 2023
13.1.1. Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Core needle biopsy
13.1.1.2. Vacuum-assisted core biopsy
13.1.1.3. Fine needle aspiration biopsy
13.1.1.4. Stereotactic core needle biopsy
13.1.1.5. Surgical biopsy
13.1.1.6. Others
13.1.2. Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.2.1. Needles
13.1.2.2. Forceps
13.1.2.3. Guns
13.1.2.4. Others
13.1.3.Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.3.1. Ultrasound-guided biopsy
13.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
13.1.3.3. Mammography guided stereotactic guided biopsy
13.1.3.4. Others
13.1.4.End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Clinics
13.1.4.3. Ambulatory surgical centres
13.1.4.4. Laboratories
13.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezula
13.1.5.5. Rest of Latin America
13.1.6. Latin America Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
13.1.7. Latin America Breast Biopsy Devices Market Dynamics - Trends
14. MIDDLE EAST & AFRICA BREAST BIOPSY DEVICES MARKET ANALYSIS,2012-2016 AND FORECAST 2017 - 2023
14.1.1.Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Core needle biopsy
14.1.1.2. Vacuum-assisted core biopsy
14.1.1.3. Fine needle aspiration biopsy
14.1.1.4. Stereotactic core needle biopsy
14.1.1.5. Surgical biopsy
14.1.1.6. Others
14.1.2.Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.2.1. Needles
14.1.2.2. Forceps
14.1.2.3. Guns
14.1.2.4. Others
14.1.3.Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.3.1. Ultrasound-guided biopsy
14.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
14.1.3.3. Mammography guided stereotactic guided biopsy
14.1.3.4. Others
14.1.4.End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Clinics
14.1.4.3. Ambulatory surgical centres
14.1.4.4. Laboratories
14.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. Middle East & Africa Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
14.1.7. Middle East & Africa Mammography guided stereotactic guided biopsy Dynamics - Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Medtronic, Inc. (Ireland)
15.2.2. Becton, Dickinson and Company (U.S.)
15.2.3. Hologic Inc. (U.S.)
15.2.4. C.R. Bard, Inc. (U.S.)
15.2.5. Planmed Oy (Finland)
15.2.6. Scion Medical Technologies, LLC (U.S.)
15.2.7. Leica Biosystems (Danaher Corporation)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRON
2. GLOBAL BREAST BIOPSY DEVICES MARKET INTRODUCTION
2.1. Global Breast Biopsy Devices Market – Taxonomy
2.2. Global Breast Biopsy Devices Market–Definitions
2.2.1. Device Type
2.2.2. Procedure Type
2.2.3. Guidance Type
2.2.4. End User
2.2.5. Region
3. GLOBAL BREAST BIOPSY DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Breast Biopsy Devices Market Dynamics – Factors Impact Analysis
3.6. Global Breast Biopsy Devices Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Breast Biopsy Devices Market– Product Innovations
3.8. Competitor Landscape
4. GLOBAL BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 – 2023
4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL BREAST BIOPSY DEVICES MARKET, BY DEVICE TYPE, 2012 - 2023
5.1. Core needle biopsy
5.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Vacuum-assisted core biopsy
5.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Fine needle aspiration biopsy
5.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Stereotactic core needle biopsy
5.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Surgical biopsy
5.5.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
6. GLOBAL BREAST BIOPSY DEVICES MARKET , BY PROCEDURE TYPE, 2016-2016 AND FORECAST 2017 - 2023
6.1. Needles
6.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.2. Forceps
6.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Guns
6.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
7. GLOBAL BREAST BIOPSY DEVICES MARKET FORECAST, BY GUIDANCE TYPE, 2012-2016 AND FORECAST 2017 - 2023
7.1. Ultrasound-guided biopsy
7.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Magnetic resonance imaging (MRI) guided biopsy
7.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Mammography guided stereotactic guided biopsy
7.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.4.3. Market Opportunity Analysis
8. GLOBAL BREAST BIOPSY DEVICES MARKET FORECAST, BY END USER, 2012-2016 AND FORECAST 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Clinics
8.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Ambulatory surgical centres
8.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
8.4. Laboratories
8.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.4.3. Market Opportunity Analysis
8.5. Laboratories
8.5.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.5.3. Market Opportunity Analysis
9. GLOBAL BREAST BIOPSY DEVICES MARKET FORECAST, BY REGION, 2012-2016 AND FORECAST 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East & Africa
9.5.1. Market Analysis, 2012-2016 and Forecast, 2012-2016 and Forecast 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User and Region, 2012-2016 and Forecast 2017 – 2023
10. NORTH AMERICA BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 - 2023
10.1.1.Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Core needle biopsy
10.1.1.2. Vacuum-assisted core biopsy
10.1.1.3. Fine needle aspiration biopsy
10.1.1.4. Stereotactic core needle biopsy
10.1.1.5. Surgical biopsy
10.1.1.6. Others
10.1.2.Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.2.1. Needles
10.1.2.2. Forceps
10.1.2.3. Guns
10.1.2.4. Others
10.1.3.Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.3.1. Ultrasound-guided biopsy
10.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
10.1.3.3. Mammography guided stereotactic guided biopsy
10.1.3.4. Others
10.1.4.End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Clinics
10.1.4.3. Ambulatory surgical centres
10.1.4.4. Laboratories
10.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.5.1. U.S
10.1.5.2. Canada
10.1.6. North America Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
10.1.7. North America Breast Biopsy Devices Market Dynamics - Trends
11. EUROPE BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 - 2023
11.1.1. Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Core needle biopsy
11.1.1.2. Vacuum-assisted core biopsy
11.1.1.3. Fine needle aspiration biopsy
11.1.1.4. Stereotactic core needle biopsy
11.1.1.5. Surgical biopsy
11.1.1.6. Others
11.1.2. Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.2 Needles
11.1.2.1. Forceps
11.1.2.2. Guns
11.1.2.3. Others
11.1.3. Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.3.1. Ultrasound-guided biopsy
11.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
11.1.3.3. Mammography guided stereotactic guided biopsy
11.1.3.4. Others
11.1.4. End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Clinics
11.1.4.3. Ambulatory surgical centres
11.1.4.4. Laboratories
11.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Italy
11.1.5.5. Spain
11.1.5.6. Poland
11.1.5.7. Russia
11.1.5.8. Rest of Europe
11.1.6. Europe Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
11.1.7. Europe Breast Biopsy Devices Market Dynamics - Trends
12. ASIA-PACIFIC BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 - 2023
12.1.1. Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Core needle biopsy
12.1.1.2. Vacuum-assisted core biopsy
12.1.1.3. Fine needle aspiration biopsy
12.1.1.4. Stereotactic core needle biopsy
12.1.1.5. Surgical biopsy
12.1.1.6. Others
12.1.2. Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.2.1. Needles
12.1.2.2. Forceps
12.1.2.3. Guns
12.1.2.4. Others
12.1.3. Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.3.1. Ultrasound-guided biopsy
12.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
12.1.3.3. Mammography guided stereotactic guided biopsy
12.1.3.4. Others
12.1.4. End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Clinics
12.1.4.3. Ambulatory surgical centres
12.1.4.4. Laboratories
12.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of APAC
12.1.6. Asia-Pacific Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
12.1.7. Asia-Pacific Breast Biopsy Devices Market Dynamics - Trends
13. LATIN AMERICA BREAST BIOPSY DEVICES MARKET ANALYSIS, 2012-2016 AND FORECAST 2017 - 2023
13.1.1. Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Core needle biopsy
13.1.1.2. Vacuum-assisted core biopsy
13.1.1.3. Fine needle aspiration biopsy
13.1.1.4. Stereotactic core needle biopsy
13.1.1.5. Surgical biopsy
13.1.1.6. Others
13.1.2. Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.2.1. Needles
13.1.2.2. Forceps
13.1.2.3. Guns
13.1.2.4. Others
13.1.3.Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.3.1. Ultrasound-guided biopsy
13.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
13.1.3.3. Mammography guided stereotactic guided biopsy
13.1.3.4. Others
13.1.4.End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Clinics
13.1.4.3. Ambulatory surgical centres
13.1.4.4. Laboratories
13.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezula
13.1.5.5. Rest of Latin America
13.1.6. Latin America Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
13.1.7. Latin America Breast Biopsy Devices Market Dynamics - Trends
14. MIDDLE EAST & AFRICA BREAST BIOPSY DEVICES MARKET ANALYSIS,2012-2016 AND FORECAST 2017 - 2023
14.1.1.Device Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Core needle biopsy
14.1.1.2. Vacuum-assisted core biopsy
14.1.1.3. Fine needle aspiration biopsy
14.1.1.4. Stereotactic core needle biopsy
14.1.1.5. Surgical biopsy
14.1.1.6. Others
14.1.2.Procedure Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.2.1. Needles
14.1.2.2. Forceps
14.1.2.3. Guns
14.1.2.4. Others
14.1.3.Guidance Type Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.3.1. Ultrasound-guided biopsy
14.1.3.2. Magnetic resonance imaging (MRI) guided biopsy
14.1.3.3. Mammography guided stereotactic guided biopsy
14.1.3.4. Others
14.1.4.End User Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Clinics
14.1.4.3. Ambulatory surgical centres
14.1.4.4. Laboratories
14.1.5. Country Analysis Forecast (2012-2016 and Forecast 2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. Middle East & Africa Breast Biopsy Devices Market - Opportunity Analysis Index, By Device Type, Procedure Type, Guidance Type, End User, and Country, 2012-2016 and Forecast 2017 – 2023
14.1.7. Middle East & Africa Mammography guided stereotactic guided biopsy Dynamics - Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Medtronic, Inc. (Ireland)
15.2.2. Becton, Dickinson and Company (U.S.)
15.2.3. Hologic Inc. (U.S.)
15.2.4. C.R. Bard, Inc. (U.S.)
15.2.5. Planmed Oy (Finland)
15.2.6. Scion Medical Technologies, LLC (U.S.)
15.2.7. Leica Biosystems (Danaher Corporation)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRON
